|
|
Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges |
Tangchun Wu() |
School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
|
|
|
Corresponding Author(s):
Tangchun Wu
|
Just Accepted Date: 09 October 2020
Online First Date: 23 October 2020
Issue Date: 24 December 2020
|
|
1 |
A Pan, L Liu, C Wang, H Guo, X Hao, Q Wang, J Huang, N He, H Yu, X Lin, S Wei, T Wu. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA 2020; 323(19): 1915–1923
https://doi.org/10.1001/jama.2020.6130
pmid: 32275295
|
2 |
MJ Mulligan. An inactivated virus candidate vaccine to prevent COVID-19. JAMA 2020 Aug 13. [Epub ahead of print] doi: 10.1001/jama.2020.15539
https://doi.org/10.1001/jama.2020.15539
pmid: 32789500
|
3 |
G Alter, R Seder. The power of antibody-based surveillance. N Engl J Med 2020 Sep 1. [Epub ahead of print] doi: 10.1056/NEJMe2028079
https://doi.org/10.1056/NEJMe2028079
pmid: 32871061
|
4 |
DS Stephens, MJ McElrath. COVID-19 and the path to immunity. JAMA 2020 Sep 11. [Epub ahead of print] doi: 10.1001/jama.2020.16656
https://doi.org/10.1001/jama.2020.16656
pmid: 32915201
|
5 |
KK To, IF Hung, JD Ip, AW Chu, WM Chan, AR Tam, CH Fong, S Yuan, HW Tsoi, AC Ng, LL Lee, P, Wan E Tso, WK To, D Tsang, KH Chan, JD Huang, KH Kok, VC Cheng, KY Yuen. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis 2020 Aug 25. [Epub ahead of print] doi: 10.1093/cid/ciaa1275
https://doi.org/10.1093/cid/ciaa1275
pmid: 32840608
|
6 |
Y Tan, F Liu, X Xu, Y Ling, WJ Huang, ZQ Zhu, MQ Guo, YX Lin, ZY Fu, DG Liang, TF Zhang, J Fan, M Xu, HZ Lu, SJ Chen. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med 2020; 14(6): 746–751
https://doi.org/10.1007/s11684-020-0822-5
pmid: 33017040
|
7 |
DF Gudbjartsson, GL Norddahl, P Melsted, K Gunnarsdottir, H Holm, E Eythorsson, AO Arnthorsson, D Helgason, K Bjarnadottir, RF Ingvarsson, B Thorsteinsdottir, S Kristjansdottir, K Birgisdottir, AM Kristinsdottir, MI Sigurdsson, GA Arnadottir, EV Ivarsdottir, M Andresdottir, F Jonsson, AB Agustsdottir, J Berglund, B Eiriksdottir, R Fridriksdottir, EE Gardarsdottir, M Gottfredsson, OS Gretarsdottir, S Gudmundsdottir, KR Gudmundsson, TR Gunnarsdottir, A Gylfason, A Helgason, BO Jensson, A Jonasdottir, H Jonsson, T Kristjansson, KG Kristinsson, DN Magnusdottir, OT Magnusson, LB Olafsdottir, S, Rognvaldsson L le Roux, G, Sigmundsdottir A Sigurdsson, G Sveinbjornsson, KE Sveinsdottir, M, Sveinsdottir EA Thorarensen, B Thorbjornsson, M Thordardottir, J Saemundsdottir, SH Kristjansson, KS Josefsdottir, G Masson, G Georgsson, M Kristjansson, A Moller, R Palsson, T Gudnason, U Thorsteinsdottir, I Jonsdottir, P Sulem, K Stefansson. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med 2020 Sep 1. [Epub ahead of print] doi: 10.1056/NEJMoa2026116
https://doi.org/10.1056/NEJMoa2026116
pmid: 32871063
|
8 |
FJ Ibarrondo, JA Fulcher, D Goodman-Meza, J Elliott, C Hofmann, MA Hausner, KG Ferbas, NH Tobin, GM Aldrovandi, OO Yang. Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild Covid-19. N Engl J Med 2020; 383(11): 1085–1087
pmid: 32706954
|
9 |
QX Long, BZ Liu, HJ Deng, GC Wu, K Deng, YK Chen, P Liao, JF Qiu, Y Lin, XF Cai, DQ Wang, Y Hu, JH Ren, N Tang, YY Xu, LH Yu, Z Mo, F Gong, XL Zhang, WG Tian, L Hu, XX Zhang, JL Xiang, HX Du, HW Liu, CH Lang, XH Luo, SB Wu, XP Cui, Z Zhou, MM Zhu, J Wang, CJ Xue, XF Li, L Wang, ZJ Li, K Wang, CC Niu, QJ Yang, XJ Tang, Y Zhang, XM Liu, JJ Li, DC Zhang, F Zhang, P Liu, J Yuan, Q Li, JL Hu, J Chen, AL Huang. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020; 26(6): 845–848
https://doi.org/10.1038/s41591-020-0897-1
pmid: 32350462
|
10 |
Q Lei, Y Li, HY Hou, Wang F, Fan XL. Antibody dynamics to SARS-CoV-2 in asymptomatic and mild COVID-19 patients. medRxiv 2020. Preprint posted July 9
https://doi.org/10.1101/ 2020.07.09.20149633
|
11 |
J Wu, BY Liang, CR Chen, Wang H, Zheng X. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19. medRxiv 2020. Preprint posted July 21
https://doi.org/10.1101/2020.07.21.20159178
|
12 |
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, N Hengartner, EE Giorgi, T Bhattacharya, B Foley, KM Hastie, MD Parker, DG Partridge, CM Evans, TM Freeman, TI de Silva, COVID-19 Genomics Group Sheffield ; C McDanal, LG Perez, H Tang, A Moon-Walker, SP Whelan, CC LaBranche, EO Saphire, DC Montefiori, A Angyal, RL Brown, L Carrilero, LR Green, DC Groves, KJ Johnson, AJ Keeley, BB Lindsey, PJ Parsons, M Raza, S Rowland-Jones, N Smith, RM Tucker, D Wang, MD Wyles. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 2020; 182(4): 812–827.e19
https://doi.org/10.1016/j.cell.2020.06.043
pmid: 32697968
|
13 |
M Leslie. T cells found in coronavirus patients ‘bode well’ for long-term immunity. Science 2020; 368(6493): 809–810
https://doi.org/10.1126/science.368.6493.809
pmid: 32439770
|
14 |
T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, A, Olsson S Llewellyn-Lacey, H Kamal, G Bogdanovic, S Muschiol, DJ Wullimann, T Kammann, J Emgård, T Parrot, E Folkesson; COVID-19 Study Group, Rooyackers O Karolinska, LI Eriksson, JI Henter, A Sönnerborg, T Allander, J Albert, M Nielsen, J Klingström, S Gredmark-Russ, NK Björkström, JK Sandberg, DA Price, HG Ljunggren, S Aleman, M Buggert. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 2020; 183(1):158–168.e14
https://doi.org/10.1016/j.cell.2020.08.017
pmid: 32979941
|
15 |
QX Long, XJ Tang, QL Shi, Q Li, HJ Deng, J Yuan, JL Hu, W Xu, Y Zhang, FJ Lv, K Su, F Zhang, J Gong, B Wu, XM Liu, JJ Li, JF Qiu, J Chen, AL Huang. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020; 26(8): 1200–1204
https://doi.org/10.1038/s41591-020-0965-6
pmid: 32555424
|
16 |
F Wu, M Liu, A Wang, L Lu, Q Wang, C Gu, J Chen, Y Wu, S Xia, Y Ling, Y Zhang, J, Xun R Zhang, Y Xie, S Jiang, T Zhu, H Lu, Y Wen, J Huang. Evaluating the association of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild COVID-19 in Shanghai, China. JAMA Intern Med 2020 Aug 18. [Epub ahead of print] doi: 10.1001/jamainternmed.2020.4616
https://doi.org/10.1001/jamainternmed. 2020.4616
pmid: 32808970
|
17 |
X Wang, X Guo, Q Xin, Y Pan, Y Hu, J, Li Y Chu, Y Feng, Q Wang. Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients. Clin Infect Dis 2020 Jun 4. [Epub ahead of print] doi: 10.1093/cid/ciaa721
https://doi.org/10.1093/cid/ciaa721
pmid: 32497196
|
18 |
KK To, OT Tsang, WS Leung, AR Tam, TC Wu, DC Lung, CC Yip, JP Cai, JM Chan, TS Chik, DP Lau, CY Choi, LL Chen, WM Chan, KH Chan, JD Ip, AC Ng, RW Poon, CT Luo, VC Cheng, JF Chan, IF Hung, Z Chen, H Chen, KY Yuen. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20(5): 565–574
https://doi.org/10.1016/S1473-3099(20)30196-1
pmid: 32213337
|
19 |
N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, MHY Chng, M Lin, N Tan, M Linster, WN Chia, MI Chen, LF Wang, EE Ooi, S Kalimuddin, PA Tambyah, JG Low, YJ Tan, A Bertoletti. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 2020; 584(7821): 457–462
https://doi.org/10.1038/s41586-020-2550-z
pmid: 32668444
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|